DiaMedica Appoints Mark Robbins as Executive VP [Professional Services Close - Up]
(Professional Services Close - Up Via Acquire Media NewsEdge) DiaMedica Inc. reported the promotion of Mark Robbins, Ph.D., J.D., to Executive Vice President.
According to a release, Dr. Robbins joined DiaMedica in December 2012 as Vice President, Clinical and Regulatory Affairs. He will continue to oversee the Company's clinical development efforts.
"We're excited to promote Mark to the role of Executive Vice President. He has made significant contributions to DiaMedica, each demonstrating an unwavering commitment to advancing our current product portfolio, in addition to identifying other potential product opportunities," said Rick Pauls, President & CEO. "His continued leadership and vision will help ensure DiaMedica is able to achieve its longer term goal of commercialization of its products."
Prior to joining DiaMedica, Dr. Robbins spent 15 years with Upsher-Smith Laboratories, advancing to Executive Vice President, Legal, Scientific and Technical Operations, Chief Scientific Officer and Assistant Secretary, where he oversaw the clinical and regulatory strategies for several drugs ranging from R&D to manufacturing and Phase I to Phase III.
DiaMedica is a publicly traded clinical stage biopharmaceutical company.
((Comments on this story may be sent to firstname.lastname@example.org))
(c) 2014 ProQuest Information and Learning Company; All Rights Reserved.
[ Back To TMCnet.com's Homepage ]